Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02352558
Title A Study of BBI608 in Adult Patients With Advanced, Refractory Hematologic Malignancies
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Boston Biomedical, Inc
Indications

hematologic cancer

Therapies

Imatinib

Napabucasin

Bortezomib

Ibrutinib

Dexamethasone

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Rocky Mountain Cancer Centers Denver Colorado 80218 United States Details
Indiana University Indianapolis Indiana 46202 United States Details
West Clinic Germantown Tennessee 38138 United States Details
Cancer Care Centers of South Texas San Antonio Texas 78217 United States Details
Cancer Care Centers of South Texas - HOAST San Antonio Texas 78229 United States Details
Virginia Cancer Specialists, P.C. Fairfax Virginia 22031 United States Details
Virginia Oncology Associates Norfolk Virginia 23502 United States Details
Northwest Cancer Specialists, PC Vancouver Washington 98684 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field